More White than Black and Hispanic patients receive buprenorphine, naloxone, benzodiazepines in 180 days after index event
Persons receiving medication for opioid use disorder more likely to be older, White and to have public insurance
Review shows positive effects on cessation of substance use, aerobic capacity, depressive symptoms
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
Conditioned open-label placebo had no impact on the 90-day methadone dose, but did improve sleep quality
Rates of precipitated withdrawal are less than 1 percent
Nineteen independent SNPs identified that were genome-wide significant for general addiction risk factor
By summer, all federal prisons will offer medications to treat substance use disorder
Associations strongest for substance misuse and schizophrenia spectrum disorder
However, sellers and traffickers of hard drugs will still face criminal prosecution